The Cooper Companies, Inc. (COO) Earnings Call Analysis
NASDAQ · Healthcare · Medical Instruments & Supplies
Earnings Reports
-
Cooper Companies (COO) Q2 2026: Surgical Division Attracts Multiple Bids as $272M Litigation Charge Resolved
June 05, 2026
-
Cooper Companies (COO) Q1 2026: Operating Margin Surges to 26.9% as AI and Reorg Drive Efficiency
March 06, 2026
-
CooperCompanies (COO) Q4 2025: MyDay Private Label Surge Drives 5% Vision Growth as Strategic Review Advances
December 05, 2025
-
Cooper Companies (COO) Q3 2025: MyDay Fitting Sets Surge 50%, Positioning for Daily SiHy Share Rebound
August 28, 2025
-
Cooper Companies (COO) Q2 2025: MyDay, Myopia, and Surgical Devices Propel 7% Organic Growth Despite Fertility Slowdown
July 03, 2025